You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma endometrii

Showing 51 - 75 of 7,589
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Guangzhou (TACE-HACI, plus atezolizumab-bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • TACE-HACI, plus atezolizumab-bevacizumab
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 20, 2023

Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)

Recruiting
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Queen Mary Hospital
Apr 10, 2023

Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • no intervention
  • Wuhan, Hubei, China
    Renmin hosptial of Wuhan University
Jul 29, 2023

Delving Into Participation Trends in Renal Cell Carcinoma

Not yet recruiting
  • Renal Cell Carcinoma
    • San Francisco, California
      Power Life Sciences
    Oct 16, 2023

    Esophageal Cancer Trial in Tianjin (Arm A, Arm B)

    Not yet recruiting
    • Esophageal Cancer
    • Arm A
    • Arm B
    • Tianjin, Tianjin, China
      Tianjin Cancer Hospital
    Sep 24, 2023

    Hepatocellular Carcinoma Trial in Guangzhou (Lenvatinib, Tislelizumab Combined with RALOX Regimen HAIC)

    Recruiting
    • Hepatocellular Carcinoma
    • Lenvatinib, Tislelizumab Combined with RALOX Regimen HAIC
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Jul 12, 2023

    Merkel Cell Carcinoma Trial in Wollstonecraft (Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination)

    Not yet recruiting
    • Merkel Cell Carcinoma
    • Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination
    • Wollstonecraft, New South Wales, Australia
      Melanoma Institute Australia
    Nov 21, 2023

    Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity

    Not yet recruiting
    • Nasopharyngeal Carcinoma
      • Fuzhou, Fujian, China
        Department of radiation oncology, Fujian cancer hospital
      Nov 16, 2023

      Esophageal Carcinoma Trial (Immune Checkpoint Inhibitors)

      Not yet recruiting
      • Esophageal Carcinoma
      • Immune Checkpoint Inhibitors
      • (no location specified)
      Jul 6, 2023

      Immune Checkpoint Inhibitors in Genitourinary Malignancies

      Suspended
      • Carcinoma, Renal Cell
      • Carcinoma, Urothelial
      • Immune cell and CTC detection procedures
      • Durham, North Carolina
        Duke University Medical Center
      Nov 11, 2022

      Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

      Recruiting
      • Esophageal Squamous Cell Carcinoma
        • Shijiazhuang, Hebei, China
          Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
        Oct 25, 2023

        Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma Trial in Canton (ACR-368, Gemcitabine,

        Recruiting
        • Platinum-resistant Ovarian Cancer
        • +2 more
        • Mobile, Alabama
        • +7 more
        Jan 24, 2023

        Chemo, Radiation Therapy Trial in Fuzhou (Camrelizumab, Paclitaxel, Cisplatin)

        Not yet recruiting
        • Chemotherapy
        • Radiation Therapy
        • Fuzhou, China
          Fujian Medical University Union Hospital
        Apr 6, 2023

        Hepatocellular Carcinoma Trial in Seoul (Microwave ablation)

        Recruiting
        • Hepatocellular Carcinoma
        • Microwave ablation
        • Seoul, Korea, Republic of
          Seoul National University Hospital
        Oct 10, 2023

        Head and Neck Squamous Cell Carcinoma, Oral Cancer Trial in Guangzhou (Tirelizumab ,+Carboplatin+albumin-bound paclitaxel)

        Recruiting
        • Head and Neck Squamous Cell Carcinoma
        • Oral Cancer
        • Tirelizumab ,+Carboplatin+albumin-bound paclitaxel
        • Guangzhou, Guangdong, China
          Sun yat-sun memorial hospital
        Jul 10, 2023

        People Living With HIV, Oral and Oropharyngeal Cancer, and

        Not yet recruiting
        • HIV Infections
        • +2 more
        • Group Meeting (Focus Group)
        • Questionnaires
        • San Francisco, California
          University of California, San Francisco
        Sep 20, 2023

        Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Paclitaxel-albumin)

        Not yet recruiting
        • Head and Neck Squamous Cell Carcinoma
        • (no location specified)
        Oct 25, 2023

        Squamous Cell Carcinoma of Head and Neck Trial in Toronto (fMRI, Oral Pimonidazole)

        Not yet recruiting
        • Squamous Cell Carcinoma of Head and Neck
        • fMRI
        • Oral Pimonidazole
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Center
        Oct 9, 2023

        Nasopharyngeal Carcinoma Trial in Beijing (Donafenib)

        Recruiting
        • Nasopharyngeal Carcinoma
        • Beijing, Beijing, China
          Cancer Hospital of Medical College
        Nov 28, 2022

        Gastrointestinal Neuroendocrine Carcinoma Trial in Beijing (Durvalumab and Chemotherapy(oxaliplatin and capecitabine))

        Recruiting
        • Gastrointestinal Neuroendocrine Carcinoma
        • Durvalumab and Chemotherapy(oxaliplatin and capecitabine)
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Oct 1, 2023

        Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Nov 30, 2023

        Advanced Hepatocellular Carcinoma Trial in Shenzhen (GPC3 CAR-T cells)

        Recruiting
        • Advanced Hepatocellular Carcinoma
        • GPC3 CAR-T cells
        • Shenzhen, Guangdong, China
          Li Yu
        Nov 17, 2022

        Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Trial in Beijing (statins (oral atorvastatin calcium tablet

        Recruiting
        • Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
        • statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);
        • Beijing, Beijing, China
          Peking University People's Hospital
        Oct 22, 2023

        Head and Neck Carcinoma Trial in Chengdu (Whole-Course Multidisciplinary Care Intervention)

        Recruiting
        • Head and Neck Carcinoma
        • Whole-Course Multidisciplinary Care Intervention
        • Chengdu, Sichuan, China
          West China Hospital, Sichuan University
        Apr 24, 2023

        Salivary Gland Cancer Trial in Japan (Darolutamide, Goserelin)

        Recruiting
        • Salivary Gland Cancer
        • Nagoya, Aichi, Japan
        • +11 more
        Jan 21, 2023